HDAC9 and cancer: The resulting derivatives were tested for the activity of HDAC and protein kinase inhibition in various biochemical assays and EGFR or HER2 overexpressing cancer cell lines were further used to determine the cytotoxicity of the chimeric derivatives (Table 9 and Table 10).